Capecitabine-d11 – 5 mg

Brand:
Cayman
CAS:
1132662-08-8
Storage:
-20
UN-No:
Non-Hazardous - /

Capecitabine-d11 is intended for use as an internal standard for the quantification of capecitabine (Item No. 10487) by GC- or LC-MS. Capecitabine is a prodrug form of 5-fluorouracil (5-FU; Item No. 14416).{18418} It is converted to 5-FU via several enzymatic steps beginning in the liver and ending with conversion in tumor tissue by thymidine phosphorylase, an enzyme that is more concentrated in tumor tissue compared with normal tissue. Capecitabine is cytotoxic only at high concentrations in Scaber, SIHA, and MKN45 cells (IC50s = 97, 578, and 994 µM, respectively) and is inactive in a variety of cancer cell lines, including COLO 205, HCT116, and MCF-7 cells (IC50s = >1,000 µM).  

 

Available on backorder

SKU: 10010681 - 5 mg Category:

Description

An internal standard for the quantification of capecitabine by GC- or LC-MS


Formal name: 5′-deoxy-5-fluoro-N-[(pentyl-1,1,2,2,3,3,4,4,5,5,5-d11-oxy)carbonyl]-cytidine

Synonyms: 

Molecular weight: 370.4

CAS: 1132662-08-8

Purity: ≥99% deuterated forms (d1-d11)

Formulation: A crystalline solid


Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Isotopically Labeled Standards|Deuterium||Research Area